Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Influenza

Free Subscription 28.04.2025 4 Antiviral Res 1 Eur J Epidemiol 1 J Exp Med 1 J Infect Dis 1 J Virol 2 N Engl J Med 2 Pediatrics 2 PLoS Comput Biol 1 PLoS Genet 17 PLoS One 1 Proc Natl Acad Sci U S A 22 Vaccine 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antiviral Res

1. ZHU Y, Gao Z, Feng X, Hu Y, et al
   Comprehensive preclinical characterization of IPB29, a pan-coronavirus fusion inhibitor under clinical trials.
   Antiviral Res. 2025;237:106154.
   PubMed         Abstract available
   
   
2. BONNEUX B, Ceconi M, Stobbelaar K, Herschke F, et al
   Insights in the RSV L polymerase function and structure.
   Antiviral Res. 2025;237:106148.
   PubMed         Abstract available
   
   
3. BRUN J, Arman BY, Hill ML, Kiappes JL, et al
   Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals.
   Antiviral Res. 2025 Feb 23:106123. doi: 10.1016/j.antiviral.2025.106123.
   PubMed         Abstract available
   
   
4. ZIAN D, Iaconis D, Nenci S, Crusco A, et al
   The Efficiency of High-Throughput Screening (HTS) and in-silico data analysis during medical emergencies: identification of effective antiviral 3CLpro inhibitors.
   Antiviral Res. 2025 Feb 18:106119. doi: 10.1016/j.antiviral.2025.106119.
   PubMed         Abstract available
   
   

   
   Eur J Epidemiol

5. JENSEN CB, Hansen KT, Nielsen CM, Hansen SN, et al
   Cohort profile: The BiCoVac cohort - a nationwide Danish cohort to assess short and long-term symptoms following COVID-19 vaccination.
   Eur J Epidemiol. 2025;40:225-233.
   PubMed         Abstract available
   
   

   
   J Exp Med

6. MATZ HC, Ellebedy AH
   Vaccination against influenza viruses annually: Renewing or narrowing the protective shield?
   J Exp Med. 2025;222:e20241283.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. FURMANSKI M, Murcia PR
   Did horses act as intermediate hosts that facilitated the emergence of 1918 pandemic influenza?
   J Infect Dis. 2025 Apr 22:jiaf197. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. LE CTT, Kim K-H, Raha JR, Bhatnagar N, et al
   Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
   J Virol. 2025 Apr 23:e0229424. doi: 10.1128/jvi.02294.
   PubMed         Abstract available
   
   

   
   N Engl J Med

9. UYEKI TM, Dugan VG, Daskalakis DC
   Baloxavir Treatment to Reduce Influenza Virus Transmission.
   N Engl J Med. 2025;392:1652-1654.
   PubMed        
   
   
10. MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al
    Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
    N Engl J Med. 2025;392:1582-1593.
    PubMed         Abstract available
    
    

    
    Pediatrics

11. BASSETT HK, Rao S, Beck J, Brady PW, et al
    Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza.
    Pediatrics. 2025 Apr 25:e2024069111. doi: 10.1542/peds.2024-069111.
    PubMed         Abstract available
    
    
12. ZHU S, Quint J, Penton C, Hoover C, et al
    Duration of Illness in Children <18 Years Dying of Influenza in California: 2004-2023.
    Pediatrics. 2025;155:e2024069368.
    PubMed        
    
    

    
    PLoS Comput Biol

13. TEOH YC, Noor MS, Aghakhani S, Girton J, et al
    Viral escape-inspired framework for structure-guided dual bait protein biosensor design.
    PLoS Comput Biol. 2025;21:e1012964.
    PubMed         Abstract available
    
    
14. WANG M, Patsenker J, Li H, Kluger Y, et al
    Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction.
    PLoS Comput Biol. 2025;21:e1012153.
    PubMed         Abstract available
    
    

    
    PLoS Genet

15. LIEFFERINCKX C, Stern D, Peree H, Bottieau J, et al
    The identification of blood-derived response eQTLs reveals complex effects of regulatory variants on inflammatory and infectious disease risk.
    PLoS Genet. 2025;21:e1011599.
    PubMed         Abstract available
    
    

    
    PLoS One

16. SEDGHIAN A, MohammadEbrahimi S, Sartorius B, Kiani B, et al
    National spatiotemporal patterns of influenza-like illness in Iran: A pre-COVID-19 study (2015-2019).
    PLoS One. 2025;20:e0320990.
    PubMed         Abstract available
    
    
17. TOMKINS AA, Dulai G, Dulai R, Rassenberg S, et al
    Measuring the fitted filtration efficiency of cloth masks, medical masks and respirators.
    PLoS One. 2025;20:e0301310.
    PubMed         Abstract available
    
    
18. ROBINSON CC, Sganzerla D, Manfio JL, Kochhann R, et al
    Incidence, associated factors and impact of the post-COVID-19 condition in Brazil: Study protocol of an observational cohort during the Omicron phase.
    PLoS One. 2025;20:e0322466.
    PubMed         Abstract available
    
    
19. DICKINSON R, Makowski D, van Marwijk H, Ford E, et al
    Interventions for combating COVID-19 misinformation: A systematic realist review.
    PLoS One. 2025;20:e0321818.
    PubMed         Abstract available
    
    
20. VIJAYAKUMAR S, Louis DW, Corneau E, Erqou S, et al
    Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings.
    PLoS One. 2025;20:e0321964.
    PubMed         Abstract available
    
    
21. DI CHIARA C, Ferrarese M, Boracchini R, Cantarutti A, et al
    Long-term neuropsychiatric and neuropsychological impact of the pandemic in Italian COVID-19 family clusters, including children and parents.
    PLoS One. 2025;20:e0321366.
    PubMed         Abstract available
    
    
22. AL-SHAMALI HF, Dong R, Jackson M, Burback L, et al
    Suffering in silence: Accessing mental health care and repetitive transcranial magnetic stimulation (rTMS) for peripartum depression - A qualitative study.
    PLoS One. 2025;20:e0321813.
    PubMed         Abstract available
    
    
23. SHABNAM S, Zaccardi F, Yates T, Islam N, et al
    COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: A retrospective study in the United Kingdom.
    PLoS One. 2025;20:e0319438.
    PubMed         Abstract available
    
    
24. SPANYIK A, Simon D, Rigo A, Gacs B, et al
    Cynicism among medical students: An in-depth analysis of mental health dynamics and protective factors in medical education using structural equation modeling.
    PLoS One. 2025;20:e0321274.
    PubMed         Abstract available
    
    
25. BRINKMAN N, Teunis T, Choi S, Ring D, et al
    Factors associated with the presence and intensity of ongoing symptoms in Long COVID.
    PLoS One. 2025;20:e0319874.
    PubMed         Abstract available
    
    
26. BASA M, De Vries J, McDonagh D, Comiskey C, et al
    Adherence to alcohol consumption-related recommendations and predictors of heavy episodic drinking among patients with NCDs during the COVID-19 pandemic.
    PLoS One. 2025;20:e0321577.
    PubMed         Abstract available
    
    
27. SAITO MM, Katayama K, Naruse A, Ruan P, et al
    Effects of inbound attendees of a mass gathering event on the COVID-19 epidemic using individual-based simulations.
    PLoS One. 2025;20:e0321288.
    PubMed         Abstract available
    
    
28. SANCHEZ-IZQUIERDO M, Garcia-Sanchez R, Prieto-Ursua M, Mateos-Nozal J, et al
    Positive outcomes among nursing home caregivers in Spain during the COVID-19 pandemic: A qualitative interview study.
    PLoS One. 2025;20:e0320663.
    PubMed         Abstract available
    
    
29. ABRAR SM, Awasthi N, Smolyak D, Sigalo N, et al
    Auditing the fairness of the US COVID-19 forecast hub's case prediction models.
    PLoS One. 2025;20:e0319383.
    PubMed         Abstract available
    
    
30. DAWSON AJ, Bista A, Wilson AE
    Is trust a zero-sum game? What happens when institutional sources get it wrong.
    PLoS One. 2025;20:e0321743.
    PubMed         Abstract available
    
    
31. SOUCY A, Pellecer Rivera E, Siwek N, Martin L, et al
    Opportunities and challenges within green spaces during COVID-19: Perspectives of visitors and managers in Maine, USA.
    PLoS One. 2025;20:e0320800.
    PubMed         Abstract available
    
    
32. LEBEDEV M, Walsh P, Newman JW, Mutua VN, et al
    Immune mechanisms affected by cyclooxygenase inhibition combined with antiviral treatment in calves infected with bovine respiratory syncytial virus.
    PLoS One. 2025;20:e0321642.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

33. BONTORIN S, Centellegher S, Gallotti R, Pappalardo L, et al
    Mixing individual and collective behaviors to predict out-of-routine mobility.
    Proc Natl Acad Sci U S A. 2025;122:e2414848122.
    PubMed         Abstract available
    
    

    
    Vaccine

34. HONDA-OKUBO Y, Sakala IG, Li L, Bielefeldt-Ohmann H, et al
    Advax(R)-adjuvanted inactivated influenza vaccine provides accelerated protection of mice via early induction of an influenza-specific IgM response.
    Vaccine. 2025;56:127144.
    PubMed         Abstract available
    
    
35. ZHANG X, Shi H, Ross TM
    Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model.
    Vaccine. 2025;56:127156.
    PubMed         Abstract available
    
    
36. FINNEY J, Kuraoka M, Song S, Watanabe A, et al
    Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.
    Vaccine. 2025;56:127157.
    PubMed         Abstract available
    
    
37. CHAN MXJ, Wouters OJ, Chan HY, Terblanche P, et al
    Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective.
    Vaccine. 2025 Apr 10:127107. doi: 10.1016/j.vaccine.2025.127107.
    PubMed         Abstract available
    
    
38. BRUXVOORT KJ, Sy LS, Contreras R, Lewin B, et al
    Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines.
    Vaccine. 2025;53:127074.
    PubMed         Abstract available
    
    
39. OLESEN SW, Holmdahl I, Ortega-Sanchez IR, Biggerstaff M, et al
    Projecting maximum potential demand for nirsevimab to protect eligible US infants and young children against respiratory syncytial virus in the 2024/2025 season.
    Vaccine. 2025;53:127109.
    PubMed         Abstract available
    
    
40. SASANKAN S, Gathers D, Bellerose A, Pankratz VS, et al
    Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents.
    Vaccine. 2025;53:127091.
    PubMed         Abstract available
    
    
41. SHEARN C, Postavaru GI, Hylton L, Morris H, et al
    COVID-19 vaccine decision-making and the role of institutions across the pandemic in UK Black African and Black Caribbean communities.
    Vaccine. 2025;53:127071.
    PubMed         Abstract available
    
    
42. BERNARD C, Drouin J, Le Vu S, Botton J, et al
    COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study.
    Vaccine. 2025;53:127070.
    PubMed         Abstract available
    
    
43. FISHER KA, Goldthwait L, Desrochers O, Zemel M, et al
    Reasons for COVID-19 vaccination late in the pandemic: A qualitative study.
    Vaccine. 2025;53:127084.
    PubMed         Abstract available
    
    
44. FLYNN PM, Stull C, Jain VM, Evans MD, et al
    A national cross-sectional study of dentists' vaccine hesitancy and intention to provide HPV vaccines following emergency COVID-19 vaccination authorization.
    Vaccine. 2025;53:127035.
    PubMed         Abstract available
    
    
45. FELIX P, Melo AA, Costa JP, Colaco M, et al
    Exploring TLR agonists as adjuvants for COVID-19 oral vaccines.
    Vaccine. 2025;53:127078.
    PubMed         Abstract available
    
    
46. MCCOSKER LK, Dyer B, Sudarmana T, Seale H, et al
    COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis.
    Vaccine. 2025;53:127050.
    PubMed         Abstract available
    
    
47. PATRICK R, Mahale P, Ackerson BK, Hong V, et al
    Respiratory syncytial virus vaccine uptake among adults aged >/=60 years in a large, integrated healthcare system in Southern California 2023-2024.
    Vaccine. 2025;53:127033.
    PubMed         Abstract available
    
    
48. FORAN AM, Jetten J, Muldoon OT
    Religious group membership and conspiracy beliefs influence vaccine uptake: Insights from 20 European countries.
    Vaccine. 2025;53:127086.
    PubMed         Abstract available
    
    
49. KARAN S, Opdensteinen P, Ma Y, De Oliveira JFA, et al
    A replicon-based COVID-19 vaccine candidate delivered by tobacco mosaic virus-like particles.
    Vaccine. 2025;53:127063.
    PubMed         Abstract available
    
    
50. MEERAUS W, Postema A, Gray CM, Lee A, et al
    Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.
    Vaccine. 2025;53:126955.
    PubMed         Abstract available
    
    
51. ZHAO T, Xu Q, Cai X, Wang M, et al
    Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis.
    Vaccine. 2025;53:126933.
    PubMed         Abstract available
    
    
52. KADOI K, Toba J, Uehara A, Isoda N, et al
    Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2.
    Vaccine. 2025;53:126951.
    PubMed         Abstract available
    
    
53. TENGATTINI S, Bavaro T, Rinaldi F, Temporini C, et al
    Novel tuberculosis vaccines based on TB10.4 and Ag85B: State-of-art and advocacy for good practices.
    Vaccine. 2025;53:126932.
    PubMed         Abstract available
    
    
54. KEELING MJ, Hill EM, Petrou S, Tran PB, et al
    Cost-effectiveness of routine COVID-19 adult vaccination programmes in England.
    Vaccine. 2025;53:126948.
    PubMed         Abstract available
    
    
55. EYAL N, Wendler D
    Assessing the risks of current COVID-19 challenge trials systematically.
    Vaccine. 2025;53:126877.
    PubMed         Abstract available
    
    

    
    Virus Res

56. CHEN N, Jin J, Qiao B, Gao Z, et al
    JNK kinase promotes inflammatory responses by inducing the expression of the inflammatory amplifier TREM1 during influenza a virus infection.
    Virus Res. 2025;356:199577.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.